[PDF][PDF] A prognostic model based on ferroptosis-related long non-coding RNA signatures and immunotherapy responses for non-small cell lung cancer
Y Xu, B Liang, P Song - Eur Rev Med Pharmacol Sci, 2023 - slyyir.yuntsg.com
OBJECTIVE: Non-small cell lung cancer (NSCLC) ranks high in the incidence of malignant
tumors, with limited treatment options and poor prognosis. Ferroptosis is a newly discovered …
tumors, with limited treatment options and poor prognosis. Ferroptosis is a newly discovered …
[PDF][PDF] A prognostic model based on ferroptosis-related long non-coding RNA signatures and immunotherapy responses for non-small cell lung cancer
WW YI, XQ GUO, Y XU, B LIANG… - European Review for …, 2023 - europeanreview.org
OBJECTIVE: Non-small cell lung cancer (NSCLC) ranks high in the incidence of malignant
tumors, with limited treatment options and poor prognosis. Ferroptosis is a newly discovered …
tumors, with limited treatment options and poor prognosis. Ferroptosis is a newly discovered …
A prognostic model based on ferroptosis-related long non-coding RNA signatures and immunotherapy responses for non-small cell lung cancer
WW Yi, XQ Guo, Y Xu, B Liang… - European review for …, 2023 - pubmed.ncbi.nlm.nih.gov
Objective Non-small cell lung cancer (NSCLC) ranks high in the incidence of malignant
tumors, with limited treatment options and poor prognosis. Ferroptosis is a newly discovered …
tumors, with limited treatment options and poor prognosis. Ferroptosis is a newly discovered …
A prognostic model based on ferroptosisrelated long non-coding RNA signatures and immunotherapy responses for non-small cell lung cancer.
WW YI, XQ GUO, Y XU, B LIANG… - European Review for …, 2023 - search.ebscohost.com
OBJECTIVE: Non-small cell lung cancer (NSCLC) ranks high in the incidence of malignant
tumors, with limited treatment options and poor prognosis. Ferroptosis is a newly discovered …
tumors, with limited treatment options and poor prognosis. Ferroptosis is a newly discovered …
A prognostic model based on ferroptosis-related long non-coding RNA signatures and immunotherapy responses for non-small cell lung cancer
WW Yi, XQ Guo, Y Xu, B Liang… - Eur Rev Med Pharmacol …, 2023 - europeanreview.org
OBJECTIVE: Non-small cell lung cancer (NSCLC) ranks high in the incidence of malignant
tumors, with limited treatment options and poor prognosis. Ferroptosis is a newly discovered …
tumors, with limited treatment options and poor prognosis. Ferroptosis is a newly discovered …